Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

153
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
153
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

173
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
173
Glucose Transporters01:27

Glucose Transporters

22.7K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.7K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.2K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

1.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hormones, hormesis, and holistic obesity care.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Baroneurosis.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Baropsychology.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

Water and weight: the role of hydration in weight management.

JPMA. The Journal of the Pakistan Medical Association·2026
Same author

A quantum approach to the endocrinology of obesity.

Endocrine connections·2026
Same author

A Multidisciplinary Approach to Addressing Barriers in Osteoporosis Screening, Diagnosis, Therapy Sequencing, and Adherence in India.

Cureus·2026

相关实验视频

Updated: Jun 26, 2025

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
07:07

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

Published on: May 2, 2017

14.0K

葡萄糖甲轴的作用

Sanjay Kalra1, Saurabh Arora2, Nitin Kapoor3

  • 1Department of Endocrinology, Bharti Hospital, Karnal, India;University Center for Research & Development, Chandigarh University, India.

JPMA. The Journal of the Pakistan Medical Association
|May 16, 2024
PubMed
概括

定义了葡萄糖,即尽管有足够的前体,但血葡萄糖水平较低的状态. 这一代谢药物标题概述了导致真实和伪葡萄糖甲的情况.

关键词:
自免疫,反调节机制,糖尿病,葡萄糖,低血糖,胰岛素,胰岛素抵抗,营养.

更多相关视频

Biochemical Titration of Glycogen In vitro
07:16

Biochemical Titration of Glycogen In vitro

Published on: November 24, 2013

28.4K
Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism
07:59

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism

Published on: August 19, 2021

3.7K

相关实验视频

Last Updated: Jun 26, 2025

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
07:07

Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT

Published on: May 2, 2017

14.0K
Biochemical Titration of Glycogen In vitro
07:16

Biochemical Titration of Glycogen In vitro

Published on: November 24, 2013

28.4K
Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism
07:59

Spectrophotometric Methods for the Study of Eukaryotic Glycogen Metabolism

Published on: August 19, 2021

3.7K

科学领域:

  • 代谢医学是一种代谢医学.
  • 临床生物化学 临床生物化学

背景情况:

  • 葡萄糖尾症是一种鲜为人知的临床状态.
  • 具有低血葡萄糖的特征,具有足够的葡萄糖前体储存.

研究的目的:

  • 定义葡萄糖度学并刺激该领域的研究.
  • 为了分类导致葡萄糖中毒的条件.

主要方法:

  • 文献审查和概念框架的开发.
  • 葡萄糖甲状腺症的病因的分类.

主要成果:

  • 提供了葡萄糖度的定义.
  • 对真实和伪葡萄糖分类的分类. 呈现.
  • 列出了导致性状况的例子.

结论:

  • 葡萄糖体表现为一个独特的临床实体.
  • 需要进一步研究葡萄糖解的病理生理学和管理.